137 related articles for article (PubMed ID: 34366322)
1. High expression of PPM1G is associated with the progression and poor prognosis of hepatocellular carcinoma.
Xiong DL; Li Q; Wang H; Jin WL; Fan XM; Ma YY
Cancer Biomark; 2022; 34(1):13-22. PubMed ID: 34366322
[TBL] [Abstract][Full Text] [Related]
2. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
Lin YR; Yang WJ; Yang GW
Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma.
Xiao Q; Cheng Z; Kuang W; Wu H; Luo X; Wang R
Appl Bionics Biomech; 2022; 2022():8926221. PubMed ID: 35126665
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
8. The prognostic value of TPM1-4 in hepatocellular carcinoma.
Tian Z; Zhao J; Wang Y
Cancer Med; 2022 Jan; 11(2):433-446. PubMed ID: 34850589
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol-3 kinase-dependent translational regulation of Id1 involves the PPM1G phosphatase.
Xu K; Wang L; Feng W; Feng Y; Shu HK
Oncogene; 2016 Nov; 35(44):5807-5816. PubMed ID: 27065332
[TBL] [Abstract][Full Text] [Related]
10. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
11. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
12. PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6.
Chen J; Li J; Sun H; Hu T; Wang Y; Kang G; Cao M; Li X
Carcinogenesis; 2023 May; 44(1):93-104. PubMed ID: 36349938
[TBL] [Abstract][Full Text] [Related]
13. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
14. PPM1G promotes cell proliferation via modulating mutant GOF p53 protein expression in hepatocellular carcinoma.
Hu W; Ma SL; Qiong L; Du Y; Gong LP; Pan YH; Sun LP; Wen JY; Chen JN; Guan XY; Shao CK
iScience; 2024 Mar; 27(3):109116. PubMed ID: 38384839
[TBL] [Abstract][Full Text] [Related]
15. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
16. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
17. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
[TBL] [Abstract][Full Text] [Related]
18. LncAY controls BMI1 expression and activates BMI1/Wnt/β-catenin signaling axis in hepatocellular carcinoma.
Chen MH; Fu LS; Zhang F; Yang Y; Wu XZ
Life Sci; 2021 Sep; 280():119748. PubMed ID: 34174322
[TBL] [Abstract][Full Text] [Related]
19. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
[TBL] [Abstract][Full Text] [Related]
20. High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma.
Li Q; Xiong DL; Wang H; Jin WL; Ma YY; Fan XM
Onco Targets Ther; 2021; 14():2975-2988. PubMed ID: 33981147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
